Moberg Pharma
8,07
SEK
+2,22 %
Mindre end 1K følgere
MOB
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
+2,22%
+3,4%
-18,94%
-20,65%
-24,65%
-73,03%
-50,25%
-88,74%
-86,49%
Moberg Pharma is a Swedish pharmaceutical company focused on the commercialization of proprietary medicines based on proven substances. The company mainly works in nail fungus, where Moberg Pharma is developing a new external treatment. The company has agreements with commercial partners on site in Europe and Asia, among other places. The head office is in Bromma.
Læs mereMarkedsværdi
386,39 mio. SEK
Aktieomsætning
267,37 t SEK
Omsætning
9,81 mio.
EBIT %
-3.311,21 %
P/E
-
Udbytteafkast, %
-
Finanskalender
13.5
2025
Delårsrapport Q1'25
22.5
2025
Generalforsamling '25
12.8
2025
Delårsrapport Q2'25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Moberg Pharma's Annual report for 2024
Redeye: Moberg Pharma Q4’2024 - All eyes on the European market
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools